Patent · US Active

Polynucleotide fragments of an infectious human endogenous retrovirus

US8008460B2 · kind B2 · utility

0Cited by

4References

13Claims

0Family size

Assignee

Avir Green Hills Biotechnology Research Development Trade AG · AT

Inventors

Klaus Wolff · Mesa, US
Hubert Pehamberger · Wien, AT
Andreas Grassauer · Wien, AT
Thomas Muster · Wien, AT

Key dates

Filing date	Oct 30, 2008
Grant date	Aug 30, 2011
Priority date	—
Expiry date	Oct 30, 2028

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/15
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Nucleotide sequences and fragments which code for a human endogenous retrovirus which is infectious. “Fragments” according to the present invention relate also to specific fragments of the sequences inserted into the vector pCR4-Topo and deposited as MERV-env, MERV-gag, MERV-prt and MERV-pol as mentioned above. Additionally, methods of using such sequences, polypeptides encoded by such sequences, antibodies directs against such sequences, and methods and compositions relating to the same are all contemplated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.